PRIMARY SJOGREN'S SYNDROME
Clinical trials for PRIMARY SJOGREN'S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PRIMARY SJOGREN'S SYNDROME trials appear
Sign up with your email to follow new studies for PRIMARY SJOGREN'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for Sjogren's sufferers in major trial
Disease control CompletedThis study tested a drug called telitacicept in 381 adults with active primary Sjogren's syndrome, an autoimmune disease causing dry eyes and mouth. Participants received either the drug or a placebo to see if it safely reduces disease activity. The goal is to control the conditi…
Matched conditions: PRIMARY SJOGREN'S SYNDROME
Phase: PHASE3 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
COVID-19's hidden toll on autoimmune patients revealed
Knowledge-focused CompletedThis study followed 293 people with autoimmune diseases and healthy volunteers to see how COVID-19 infection or vaccination affects their immune system, inflammation, and blood vessels. Participants were grouped based on their COVID-19 history and had up to 5 visits over 12-18 mo…
Matched conditions: PRIMARY SJOGREN'S SYNDROME
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC